334 related articles for article (PubMed ID: 7050244)
1. The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages.
Kozel TR; Gotschlich EC
J Immunol; 1982 Oct; 129(4):1675-80. PubMed ID: 7050244
[TBL] [Abstract][Full Text] [Related]
2. Opsonization of encapsulated Cryptococcus neoformans by specific anticapsular antibody.
Kozel TR; Follette JL
Infect Immun; 1981 Mar; 31(3):978-84. PubMed ID: 7014468
[TBL] [Abstract][Full Text] [Related]
3. Opsonization and phagocytosis of Cryptococcus neoformans.
Kozel TR
Arch Med Res; 1993; 24(3):211-8. PubMed ID: 8298269
[TBL] [Abstract][Full Text] [Related]
4. Opsonization of Cryptococcus neoformans by human immunoglobulin G: masking of immunoglobulin G by cryptococcal polysaccharide.
McGaw TG; Kozel TR
Infect Immun; 1979 Jul; 25(1):262-7. PubMed ID: 383615
[TBL] [Abstract][Full Text] [Related]
5. Role of the capsule in phagocytosis of Cryptococcus neoformans.
Kozel TR; Pfrommer GS; Guerlain AS; Highison BA; Highison GJ
Rev Infect Dis; 1988; 10 Suppl 2():S436-9. PubMed ID: 3055212
[TBL] [Abstract][Full Text] [Related]
6. Fc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: importance of epitope specificity.
Netski D; Kozel TR
Infect Immun; 2002 Jun; 70(6):2812-9. PubMed ID: 12010967
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of a hydrophobic surface from phagocytosis of encapsulated and non-encapsulated cryptococcus neoformans.
Kozel TR
Infect Immun; 1983 Mar; 39(3):1214-9. PubMed ID: 6341232
[TBL] [Abstract][Full Text] [Related]
8. Induction of interleukin-6 mRNA in rat alveolar macrophages by in vitro exposure to both Cryptococcus neoformans and anti-C. neoformans antiserum.
Li RK; Mitchell TG
J Med Vet Mycol; 1997; 35(5):327-34. PubMed ID: 9402525
[TBL] [Abstract][Full Text] [Related]
9. Phagocytosis of Cryptococcus neoformans by rat alveolar macrophages.
BolaƱos B; Mitchell TG
J Med Vet Mycol; 1989; 27(4):203-17. PubMed ID: 2677298
[TBL] [Abstract][Full Text] [Related]
10. Localization on encapsulated Cryptococcus neoformans of serum components opsonic for phagocytosis by macrophages and neutrophils.
Kozel TR; Highison B; Stratton CJ
Infect Immun; 1984 Feb; 43(2):574-9. PubMed ID: 6363293
[TBL] [Abstract][Full Text] [Related]
11. Opsonization of Cryptococcus neoformans by human immunoglobulin G: role of immunoglobulin G in phagocytosis by macrophages.
Kozel TR; McGaw TG
Infect Immun; 1979 Jul; 25(1):255-61. PubMed ID: 383614
[TBL] [Abstract][Full Text] [Related]
12. Natural cellular resistance of beige mice against Cryptococcus neoformans.
Hidore MR; Murphy JW
J Immunol; 1986 Dec; 137(11):3624-31. PubMed ID: 3537121
[TBL] [Abstract][Full Text] [Related]
13. Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans.
Levitz SM; DiBenedetto DJ
J Immunol; 1989 Jan; 142(2):659-65. PubMed ID: 2521352
[TBL] [Abstract][Full Text] [Related]
14. Opsonization of Cryptococcus neoformans by a family of isotype-switch variant antibodies specific for the capsular polysaccharide.
Schlageter AM; Kozel TR
Infect Immun; 1990 Jun; 58(6):1914-8. PubMed ID: 2187813
[TBL] [Abstract][Full Text] [Related]
15. Binding of cryptococcal polysaccharide to Cryptococcus neoformans.
Kozel TR; Hermerath CA
Infect Immun; 1984 Mar; 43(3):879-86. PubMed ID: 6365785
[TBL] [Abstract][Full Text] [Related]
16. Concomitant but not causal association between surface charge and inhibition of phagocytosis by cryptococcal polysaccharide.
Kozel TR; Reiss E; Cherniak R
Infect Immun; 1980 Aug; 29(2):295-300. PubMed ID: 7011970
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies can affect complement deposition on the capsule of the pathogenic fungus Cryptococcus neoformans by both classical pathway activation and steric hindrance.
Zaragoza O; Casadevall A
Cell Microbiol; 2006 Dec; 8(12):1862-76. PubMed ID: 16824038
[TBL] [Abstract][Full Text] [Related]
18. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins.
Kozel TR; Wilson MA; Pfrommer GS; Schlageter AM
Infect Immun; 1989 Jul; 57(7):1922-7. PubMed ID: 2525113
[TBL] [Abstract][Full Text] [Related]
19. Molecular architecture of the Cryptococcus neoformans capsule.
Gates MA; Thorkildson P; Kozel TR
Mol Microbiol; 2004 Apr; 52(1):13-24. PubMed ID: 15049807
[TBL] [Abstract][Full Text] [Related]
20. Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans.
Valadon P; Nussbaum G; Boyd LF; Margulies DH; Scharff MD
J Mol Biol; 1996 Aug; 261(1):11-22. PubMed ID: 8760499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]